Startup Forus is betting that AI can handle the unglamorous admin side of getting prescriptions filled. That mission landed it a $1 billion valuation.

With prescription drug spending expected to exceed $1 trillion this year, there’s a massive opportunity—almost one third of Americans never fill the prescriptions that their doctors order.

“The most common experience patients have is getting a prescription,” says Kareem Zaki, a partner at Thrive Capital which invested in Forus. “But despite how common it is, it is prohibitory for patients to get the medications they think they need.”

This is a published version of the Forbes Daily newsletter, you can sign-up to get Forbes Daily in your inbox here.

FDA Commissioner Dr. Marty Makary resigned after butting heads with Republicans over his resistance to limiting the abortion pill, mifepristone.

OpenAI cofounder and CEO Sam Altman testified that he has $2 billion worth of personal stakes in companies that conduct business with the ChatGPT maker, as he faces scrutiny over potential conflicts of interest.

President Donald Trump said Nvidia chief Jensen Huang is flying with him to China, along with other high-profile American CEOs, refuting earlier reports that Huang had not been invited.

The war in Iran spiked inflation again in April, and consumers are losing purchasing power.

Consumer prices increased 3.8% year-over-year, the fastest annual growth rate in nearly three years. The energy index, which tracks the price of fuel and utilities, drove more than 40% of all price increases. At the same time, workers’ earnings are eroding, with wage growth increasing at a slower pace than inflation for the first time since 2023.

Expect things to get worse before they get better, Jennifer Timmerman, senior investment strategy analyst at the Wells Fargo Investment Institute, explained in emailed responses to Forbes Daily.

“Price pressures in the CPI will get worse for consumers, at least through the summer, before........

© Forbes